CRP and metabolic syndrome: Various cross-sectional studies indicated that serum C-reactive protein (CRP) levels were higher among individuals with increased MetS risk factors [10]–[14], and a large cohort study of healthy American women over an eight-year follow-up suggested that CRP had clinically important prognostic information to MetS [15].